Gene · 7001
Papers3,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD109 identified in circulating proteomics mitigates postoperative recurrence in chronic rhinosinusitis with nasal polyps by suppressing TGF-β1-induced epithelial-mesenchymal transition. | Int Immunopharmacol | 2024 | 38442581 | PubTator, text mining | PubMed |
| Correlation of potential diagnostic biomarkers (circulating miRNA and protein) of bipolar II disorder. | J Psychiatr Res | 2024 | 38412788 | PubTator, text mining | PubMed |
| Reticulocyte Antioxidant Enzymes mRNA Levels versus Reticulocyte Maturity Indices in Hereditary Spherocytosis, β-Thalassemia and Sickle Cell Disease. | Int J Mol Sci | 2024 | 38396832 | PubTator, text mining | PubMed |
| Plasma concentrations of thioredoxin, thioredoxin reductase and peroxiredoxin-4 can identify high risk patients and predict outcome in patients with acute coronary syndrome: A clinical observation. | Int J Cardiol | 2024 | 38382848 | PubTator, text mining | PubMed |
| Designing, DFT, biological, & molecular docking analysis of new Iron(III) & copper(II) complexes incorporating 1-{[-(2-Hydroxyphenyl)methylene]amino}-5,5-diphenylimidazolidine-2,4-dione (PHNS). | Comput Biol Chem | 2024 | 38382408 | PubTator, text mining | PubMed |
| Transcriptome and machine learning analysis of the impact of COVID-19 on mitochondria and multiorgan damage. | PLoS One | 2024 | 38295140 | PubTator, text mining | PubMed |
| PRDX2 regulates stemness contributing to cisplatin resistance and metastasis in bladder cancer. | Environ Toxicol | 2024 | 38294069 | PubTator, text mining | PubMed |
| A state-of-the-art review of the recent advances in exosome isolation and detection methods in viral infection. | Virol J | 2024 | 38291452 | PubTator, text mining | PubMed |
| Peroxiredoxin-1 as a molecular chaperone that regulates glutathione S-transferase P1 activity and drives mutidrug resistance in ovarian cancer cells. | Biochem Biophys Rep | 2024 | 38288281 | PubTator, text mining | PubMed |
| Chrysoeriol Improves the Early Development Potential of Porcine Oocytes by Maintaining Lipid Homeostasis and Improving Mitochondrial Function. | Antioxidants (Basel) | 2024 | 38275647 | PubTator, text mining | PubMed |
| An update on recent studies of extracellular vesicles and their role in hypercoagulability in thalassemia (Review). | Biomed Rep | 2024 | 38259586 | PubTator, text mining | PubMed |
| Cyclophilin A: An Independent Prognostic Factor for Survival in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab and Chemotherapy. | Cancers (Basel) | 2024 | 38254874 | PubTator, text mining | PubMed |
| The Tumor Suppressor SOCS1 Diminishes Tolerance to Oxidative Stress in Hepatocellular Carcinoma. | Cancers (Basel) | 2024 | 38254783 | PubTator, text mining | PubMed |
| Current Technologies Unraveling the Significance of Post-Translational Modifications (PTMs) as Crucial Players in Neurodegeneration. | Biomolecules | 2024 | 38254718 | PubTator, text mining | PubMed |
| Molecular Insights into the Breast and Prostate Cancer Cells in Response to the Change of Extracellular Zinc. | J Oncol | 2024 | 38249992 | PubTator, text mining | PubMed |
| Targeting Cysteine Oxidation in Thrombotic Disorders. | Antioxidants (Basel) | 2024 | 38247507 | PubTator, text mining | PubMed |
| Triptolide induces apoptosis and cytoprotective autophagy by ROS accumulation via directly targeting peroxiredoxin 2 in gastric cancer cells. | Cancer Lett | 2024 | 38246224 | PubTator, text mining | PubMed |
| CHEK2 knockout is a therapeutic target for TP53-mutated hepatocellular carcinoma. | Cell Death Discov | 2024 | 38242891 | PubTator, text mining | PubMed |
| Association between urinary arsenic concentration and genetic polymorphisms in Korean adults. | Toxicol Res | 2024 | 38223675 | PubTator, text mining | PubMed |
| Implications and progression of peroxiredoxin 2 (PRDX2) in various human diseases. | Pathol Res Pract | 2024 | 38219498 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7001/papers?page=9